Daybue (Trofinetide) Oral Solution And Powder For Oral Solution By Samay Pharma India Private Limited

First approved treatment targeting core symptoms of Rett syndrome
Contains Trofinetide, a novel synthetic analog of IGF 1 fragment
Helps improve communication and social engagement
Designed for oral administration easy to take
Available as ready to-use solution and powder form
Supports neuronal function and synaptic health
Clinically shown to reduce disease severity
Suitable for long term management under medical supervision
Developed specifically for pediatric and adult patients
Backed by targeted mechanism addressing neuroinflammation
Daybue (trofinetide) is an FDA approved prescription medicine for treating Rett syndrome in adults and children 2 years of age and older.
It works by likely reducing inflammation and supporting brain cell communication.